Canada markets open in 6 hours 9 minutes
  • S&P/TSX

    19,228.03
    -0.87 (-0.00%)
     
  • S&P 500

    4,128.80
    +31.63 (+0.77%)
     
  • DOW

    33,800.60
    +297.00 (+0.89%)
     
  • CAD/USD

    0.7962
    -0.0022 (-0.27%)
     
  • CRUDE OIL

    58.97
    -0.35 (-0.59%)
     
  • BTC-CAD

    76,573.55
    +1,221.04 (+1.62%)
     
  • CMC Crypto 200

    1,304.54
    +77.00 (+6.27%)
     
  • GOLD FUTURES

    1,741.90
    -2.90 (-0.17%)
     
  • RUSSELL 2000

    2,243.47
    +0.87 (+0.04%)
     
  • 10-Yr Bond

    1.6660
    0.0000 (0.00%)
     
  • NASDAQ futures

    13,809.75
    -19.75 (-0.14%)
     
  • VOLATILITY

    16.69
    -0.26 (-1.53%)
     
  • FTSE

    6,888.18
    -27.57 (-0.40%)
     
  • NIKKEI 225

    29,538.73
    -229.33 (-0.77%)
     
  • CAD/EUR

    0.6698
    -0.0006 (-0.09%)
     

Calyxt: Q4 Earnings Snapshot

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.

ROSEVILLE, Minn. (AP) _ Calyxt Inc. (CLXT) on Thursday reported a loss of $13.4 million in its fourth quarter.

On a per-share basis, the Roseville, Minnesota-based company said it had a loss of 37 cents. Losses, adjusted for non-recurring costs, were 33 cents per share.

The genetically modified food company posted revenue of $13.9 million in the period.

For the year, the company reported that its loss widened to $44.8 million, or $1.32 per share. Revenue was reported as $23.9 million.

Calyxt shares have more than doubled since the beginning of the year. In the final minutes of trading on Thursday, shares hit $8.93, a rise of 36% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CLXT at https://www.zacks.com/ap/CLXT